Cervical Cancer Vaccines will Be Available for $4.50 in Poor Nations
Pharmaceutical companies Merck and GlaxoSmithKline will provide cervical cancer vaccines for as little $4.50 a dose in poor countries to fight high rates of deaths from cervical cancer.
The drugs Gardasil and Cervarix, made by Merck and GlaxoSmithKline respectively, prevent human papillomavirus (HPV), which is a leading cause of cervical cancer. In developed nations deaths caused by cervical cancer are uncommon, but cervical cancer is the most fatal form of cancer in women in poorer nations. On average 275,000 women die from cervical cancer a year and 85% are from poor nations.
Global Alliance for Vaccines and Immunizations (GAVI) will be purchasing and distributing the vaccines. The executive director said in a statement, "By 2020 we hope to reach more than 30 million girls in more than 40 countries." GAVI board member and former Health Minister of Rwanda told reporters, "Developing countries bear an increasing burden of cervical cancer and it is only right that our girls should have the same protection as girls in other countries."
Media Resources: Businessweek 5/9/2013; New York Times 5/9/2013; Reuters 5/9/2013
12/12/2013 Feminist Majority Celebrates Introduction of Family and Medical Insurance Leave Act (FAMILY Act) - WASHINGTON -- Feminist Majority today celebrates and applauds Congresswoman Rosa DeLauro (D-CT) and Senator Kirsten Gillibrand (D-NY) for introducing the critically-needed paid family medical leave legislation.
The Family and Medical Insurance Leave Act (FAMILY Act) will allow workers to take paid time off to address a serious illness of their own, a spouse, parent or child or to care for a new baby or adopted child. . . .
12/12/2013 Senate Confirms Two Women To DC Circuit Court - The US Senate confirmed Patricia Millett and Nina Pillard to the US Court of Appeals for the District of Columbia Circuit this week, making this the first time the court has had five active female judges.The court is the second most important in the US because of its jurisdiction over most federal agencies.
The Senate confirmed Patricia Millett by a 56-38 vote on Tuesday. . . .